Tag Archives: Pfizer

He added that the vaccine approval process must be guided by science so the public can trust that it is safe and effective. “With cases increasing once again, it is imperative that we increase our production of personal protective equipment, to ensure that our courageous healthcare workers have what they …

Ugur Sahin, CEO and co-founder of the German biotechnology company BioNTech. (ARCHIVE) Frankfurt: The positive data on the COVID-19 vaccine from BioNTech and its American partner Pfizer Inc is an unlikely success for the married couple behind the German biotech company, which has dedicated their lives to harnessing the immune …

The company said it is reaching a critical milestone in its vaccine program (Representative) A vaccine developed jointly by Pfizer and BioNTech was 90 percent effective in preventing Covid-19 infections in ongoing phase 3 trials, the companies announced Monday. The statement came as coronavirus cases skyrocketed around the world and …

Protection in patients was achieved seven days after the second of two doses and 28 days after the first, according to preliminary findings. A vaccine developed jointly by Pfizer and BioNTech was 90% effective in preventing Covid-19 infections in ongoing phase 3 trials, the companies announced Monday. Protection in patients …

The coronavirus disease (Covid-19) vaccine, which is being developed by US pharmaceutical giant Pfizer and German biotechnology company BioNTech, is 90% effective in preventing infections in ongoing phase 3 trials, Pfizer announced on Monday. Monday. “The first set of results from our Phase 3 Covid-19 vaccine trial provides initial evidence …

The schedule now allows for a possible U.S. authorization of a coronavirus vaccine this year. Pfizer Inc said on Friday that it could apply for authorization of the COVID-19 vaccine it is developing with German partner BioNTech in late November, so it is unlikely that a vaccine will be available …

The side effects that have emerged in a large, late-stage trial of a Covid-19 vaccine candidate from Pfizer Inc. and BioNTech SE are in line with those seen in smaller initial studies, a positive sign for one of the pioneers in the career. for a drink. The partners have not …

An effective vaccine may be the only real protection against Covid-19 as it stands, but don’t pin your hopes on getting it anytime soon. As India’s death toll from Covid surpasses one lakh, knowledge from the scientific community and government officials suggest that it could take up to two years …

Pfizer Inc said Tuesday that participants were mostly showing mild to moderate side effects when given the company’s experimental coronavirus vaccine or a placebo in an ongoing late-stage study. The company said in a presentation to investors that side effects include fatigue, headache, chills and muscle pain. Some participants in …

Pharmaceutical giant Pfizer is likely to give an update on its Covid-19 vaccine in late October on whether a COVID-19 (BNT162b2) vaccine it is developing is successful, and will submit it for approval immediately if that’s the case, according to reports. . Pfizer has enrolled 23,000 patients in vaccine trials …